Bin1 Attenuation Suppresses Experimental Colitis by Enforcing Intestinal Barrier Function
Digestive Diseases and Sciences, 04/24/2012
Chang MY et al. – Bin1 is a genetic modifier of experimental colitis that controls the paracellular pathway of transcellular ion transport regulated by cellular tight junctions. The findings offer a preclinical validation of Bin1 as a novel therapeutic target for inflammatory bowel disease (IBD) treatment.